3 Jefferies Group Cabaletta Bio Trades
Jefferies Group's position in Cabaletta Bio is currently worth $3.08M. That's 0.05% of their equity portfolio (260th largest holding). The investor owns 2.32% of the outstanding Cabaletta Bio stock. The first Cabaletta Bio trade was made in Q4 2022. Since then Jefferies Group bought shares one more times and sold shares on one occasions. The investor's estimated purchase price is $3.11M, resulting in a loss of 1.2%.
News about Cabaletta Bio Inc and Jefferies Group
MMAT, PRCH and CABA among mid-day movers
Gainers: Opiant Pharmaceuticals OPNT +113%.ToughBuilt Industries TBLT +57%.Porch Group (PRCH) +32%.Yiren Digital YRD +30%.PDS Biotechnology PDSB +28%.Meta Ma...
DRUG, CABA and ALLR among mid-day movers
Gainers: Bright Minds Biosciences (DRUG) +90%.Graphex Group GRFX +59%.Minerva Neurosciences NERV +52%.Cabaletta Bio (CABA) +38%.Signify Health SGFY +33%.Summ...